Medicare Enrolled
Dr. Inna Tovbina, M.D.
Legal Medicine · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tovbina from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tovbina?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tovbina
Dr. Inna Tovbina is a legal medicine specialist in Brooklyn, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tovbina performed 2,971 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Tovbina received a total of $20,652 from 51 pharmaceutical and/or device companies across 493 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tovbina is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 15% volume in NY
$20,652 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,971
Medicare services
Top 15% in NY for legal medicine
Not available
Unique patients (not deduplicated)
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
597 | $74 | $125 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
575 | $57 | $114 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
340 | $8 | $15 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
207 | $43 | $87 |
| Denosumab injection (Prolia/Xgeva) | 202 | $1 | $1 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
171 | $13 | $33 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
168 | $12 | $27 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
144 | $62 | $128 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
144 | $1 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
122 | $118 | $230 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
118 | $1 | $15 |
| Annual depression screening | 62 | $22 | $34 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
50 | $64 | $118 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 46 | $20 | $30 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
13 | $108 | $110 |
| Vaccine administration The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself. |
12 | $17 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
9.7% high complexity
16.5% medium
73.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$20,652
Total received (2018-2024)
Avg $2,950/year across 7 years
Top 4% in NY for legal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
493
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,621
2023
$2,973
2022
$3,619
2021
$2,759
2020
$1,874
2019
$3,007
2018
$3,800
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$577
Amgen Inc.
$432
ABBVIE INC.
$340
Boehringer Ingelheim Pharmaceuticals, Inc.
$249
Ardelyx, Inc.
$197
IRONWOOD PHARMACEUTICALS, INC
$158
SANOFI-AVENTIS U.S. LLC
$148
AIMMUNE THERAPEUTICS, INC.
$141
Merck Sharp & Dohme LLC
$104
Novartis Pharmaceuticals Corporation
$49
Gilead Sciences, Inc.
$48
Exact Sciences Corporation
$33
GlaxoSmithKline, LLC.
$30
Sumitomo Pharma America, Inc.
$30
Phathom Pharmaceuticals, Inc.
$28
Novo Nordisk Inc
$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
Lilly USA, LLC
$17
Top 3 companies account for 51.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$4,368
AstraZeneca Pharmaceuticals LP
$1,794
AbbVie Inc.
$1,749
ABBVIE INC.
$1,504
Amarin Pharma Inc.
$1,175
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,097
SANOFI-AVENTIS U.S. LLC
$1,083
Novo Nordisk Inc
$816
Lilly USA, LLC
$722
GlaxoSmithKline, LLC.
$560
E.R. Squibb & Sons, L.L.C.
$536
Allergan Inc.
$488
Novartis Pharmaceuticals Corporation
$415
PFIZER INC.
$397
Cumberland Pharmaceuticals, Inc.
$309
Janssen Pharmaceuticals, Inc
$302
Merck Sharp & Dohme LLC
$270
Synergy Pharmaceuticals Inc
$268
Ironwood Pharmaceuticals, Inc
$253
Ardelyx, Inc.
$197
Avanir Pharmaceuticals, Inc.
$183
Sumitomo Pharma America, Inc.
$162
Horizon Therapeutics plc
$161
IRONWOOD PHARMACEUTICALS, INC
$158
NESTLE HEALTHCARE NUTRITION INC.
$146
AIMMUNE THERAPEUTICS, INC.
$141
BIOTRONIK INC.
$126
Allergan, Inc.
$110
VIVUS, Inc.
$110
VIVUS LLC
$105
Nestle HealthCare Nutrition Inc.
$105
Takeda Pharmaceuticals U.S.A., Inc.
$103
Biohaven Pharmaceuticals, Inc.
$102
Endo Pharmaceuticals Inc.
$102
Bayer HealthCare Pharmaceuticals Inc.
$67
Merck Sharp & Dohme Corporation
$51
Gilead Sciences, Inc.
$48
Hikma Pharmaceuticals USA
$40
Philips Electronics North America Corporation
$39
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$37
ARBOR PHARMACEUTICALS, INC.
$36
Exact Sciences Corporation
$33
Phathom Pharmaceuticals, Inc.
$28
Sunovion Pharmaceuticals Inc.
$25
IBSA Pharma Inc.
$25
Kowa Pharmaceuticals America, Inc.
$23
Amneal Pharmaceuticals LLC
$20
Astellas Pharma US Inc
$17
Novum Pharma, LLC
$17
West-Ward Pharmaceuticals
$16
Arbor Pharmaceuticals, Inc.
$15
Top 3 companies account for 38.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AIRSUPRA · AMITIZA · ANORO · AREXVY · Aimovig · Alcortin A · Amitiza · BELSOMRA · BREZTRI · CHANTIX · CREON · Cologuard Collection Kit · DUPIXENT · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · GEMTESA · IBSRELA · INVOKANA · JANUVIA · JARDIANCE · KRISTALOSE · Kerendia · LEQVIO · LINZESS · LOKELMA · Linzess · Livalo · MAVYRET · MOTEGRITY · MOUNJARO · MYRBETRIQ · Mitigare · NAMZARIC · NASCOBAL · NUEDEXTA · NURTEC ODT · Otezla · Ozempic · PANCREAZE · PENNSAID · PRADAXA · PRALUENT · PREVNAR - 13 · PREVNAR 20 · Pancreaze · Prolia · QULIPTA · Qsymia · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SYNTHROID · TEPEZZA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · Tirosint · Tresiba · Trulance · UBRELVY · UNITHROID · VERQUVO · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · XARELTO · XIFAXAN · ZENPEP
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Legal medicines in nearby ZIP areas
116
County median income
$78,548
Nearest hospital to ZIP centroid (approximate)
SOUTH BROOKLYN HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tovbina is a clinical cardiology specialist, with above-average Medicare volume (top 15% in NY), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tovbina experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Tovbina performed 597 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Tovbina receive payments from pharmaceutical companies?
Yes. Dr. Tovbina received a total of $20,652 from 51 companies across 493 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tovbina's costs compare to other legal medicines in Brooklyn?
Dr. Tovbina's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tovbina) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Legal Medicines in Brooklyn
Browse legal medicines in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Legal Medicines in NY
Legal medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Legal Medicines in NY
Which NY legal medicines receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology